TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02186886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01594411 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study NCT03085212 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT04145505 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03099109 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00114764 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT00405275 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00855894 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00855894 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01802892 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02852954 — Predictive Biomarker (PRD): PIBF1 mRNA
Genes: PIBF1; C13orf24; PIBF
Study NCT01018251 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT03731169 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03595982 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00415246 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT01116063 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02462889 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04386850 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04386850 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04386850 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04386850 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04386850 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04412616 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02996240 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02894788 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00004256 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00242944 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00242944 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00109239 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06002997 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT02875366 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02274311 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03904862 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT03827070 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00342472 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02311140 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT00756821 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT02227433 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02951585 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03185325 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01076270 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01076270 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01979042 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00446225 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01805674 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT02317003 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04255368 — Predictive Biomarker (PRD): FMO3 mRNA
Genes: FMO3
Study NCT01855490 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT01640067 — Predictive Biomarker (PRD): SLA mRNA
Genes: SLA; SLAP; SLAP1
Study NCT00414973 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00984152 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02289066 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04652102 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03884556 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study NCT02389231 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03359551 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study NCT02980263 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04323917 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04323917 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study NCT04555811 — Predictive Biomarker (PRD): FATE1 mRNA
Genes: FATE1; FATE
Study NCT04804111 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03250819 — Predictive Biomarker (PRD): HCG22 mRNA
Genes: HCG22; G2; PBMUCL2
Study NCT03250819 — Predictive Biomarker (PRD): SRSF3 mRNA
Genes: SRSF3; SFRS3; SRP20
Study NCT03250819 — Predictive Biomarker (PRD): FKBP4 mRNA
Genes: FKBP4; FKBP52
Study NCT03250819 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): FKBP5 mRNA
Genes: FKBP5; AIG6; FKBP51
Study NCT03250819 — Predictive Biomarker (PRD): NR3C1 mRNA
Genes: NR3C1; GRL
Study NCT00001797 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01982669 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02466906 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03112499 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01238705 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01238705 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02935907 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT02935907 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06117072 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01040494 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01040494 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01040494 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT01985412 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT02992912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02892734 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02892734 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01685060 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02513355 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02513355 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01116128 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT02548832 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02548832 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04677335 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03154905 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Chitinase-3-like protein 1
Genes: CHI3L1
Study NCT01305161 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT00958113 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00958113 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00958113 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT00958113 — Predictive Biomarker (PRD): PTPN2 mRNA
Genes: PTPN2; PTPT
Study NCT00958113 — Predictive Biomarker (PRD): PTPN22 mRNA
Genes: PTPN22; PTPN8
Study NCT00897715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00897715 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00897715 — Safety Biomarker (SAF): Interleukin 1
Study NCT01707290 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04781426 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03160872 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04161313 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02177461 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03261037 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03354897 — Safety Biomarker (SAF): Uromodulin
Genes: UMOD
Study NCT03354897 — Predictive Biomarker (PRD): SLC12A1 mRNA
Genes: SLC12A1; NKCC2
Study NCT02620995 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00993538 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT00003991 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02401776 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01551628 — Safety Biomarker (SAF): Arginase-1
Genes: ARG1
Study NCT00174304 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04366089 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01945190 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT00182546 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01526655 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00452764 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1
Study NCT01598961 — Predictive Biomarker (PRD): LSR mRNA
Genes: LSR; ILDR3; LISCH
Study NCT00999986 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT00452244 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00452244 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03013426 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00572663 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04443257 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04876638 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT05072834 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01955681 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01955681 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04122521 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03221647 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT02044380 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02044380 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00967330 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT04547127 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02783924 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT02783924 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT03447587 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study NCT01277926 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02856399 — Predictive Biomarker (PRD): MNDA mRNA
Genes: MNDA
Study NCT02058706 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT02789072 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02168621 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00256178 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00256178 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT02502149 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT04282109 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04282109 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01376908 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02289833 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02016534 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03817125 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02913794 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00927589 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04857489 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03373279 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04647695 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00796809 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03274193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03253614 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01838369 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT00392691 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00208936 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02289118 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03876951 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03876951 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03876951 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02771873 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04372979 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01257269 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT01257269 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02675998 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT02709941 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01998906 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02394028 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00600249 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT01364012 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01364012 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00725283 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT02773147 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT01362049 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT02430389 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01203111 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01019902 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT01153815 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00711295 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT02628366 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03588091 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00682786 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT04992000 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04270890 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03330561 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02924987 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02924987 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02065635 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT00472563 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01873352 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01009762 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00002881 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03699332 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02090725 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study NCT00508599 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT00508599 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04551690 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02452125 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05084768 — Predictive Biomarker (PRD): TNFRSF1B mRNA
Genes: TNFRSF1B; TNFBR; TNFR2
Study NCT05084768 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03751176 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03751176 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00477880 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03209271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03079518 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT00200863 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00411983 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01130532 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02312622 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT04430062 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02038010 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03569410 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01312376 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT02790450 — Predictive Biomarker (PRD): ANO1 mRNA
Genes: ANO1; DOG1; ORAOV2; TAOS2; TMEM16A
Study NCT04441996 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00024570 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT01311973 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01311973 — Surrogate Endpoint (SUR): Serum intact parathyroid hormone
Study NCT01311973 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03153163 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02001389 — Predictive Biomarker (PRD): PDE10A mRNA
Genes: PDE10A
Study NCT01480323 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00758524 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04115891 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00284258 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT03497390 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03497390 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03497390 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01829672 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03659695 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04700670 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study NCT01191697 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00931190 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT00666328 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00171327 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03566043 — Predictive Biomarker (PRD): IDS mRNA
Genes: IDS; SIDS
Study NCT02079740 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT02079740 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02079740 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT02321111 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT03975894 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03975894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02686307 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02315079 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT03738553 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01766076 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03821493 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT01447251 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01308203 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01308203 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00834691 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00113763 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00522730 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT02401269 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2